Mid-afternoon market update: Dow rises 75 points; Motorsport Games shares spike higher
|Toward the end of trading Wednesday, the Dow traded up 0.24% to 31,143.93 while the NASDAQ rose 0.73% to 13,168.19. The S&P also rose, gaining 0.5% to 3,820.14.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 22,848,700 cases with around 380,820 deaths. India confirmed a total of at least 10,495,140 confirmed cases and 151,520 deaths, while Brazil reported over 8,195,630 COVID-19 cases with 204,690 deaths. In total, there were at least 91,691,960 cases of COVID-19 worldwide with over 1,964,760 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Utilities shares gained by 2% on Wednesday. Meanwhile, top gainers in the sector included TransAlta Corporation TAC 3.67%, up 4%, and The AES Corporation AES 3.25%, up 3%.
In trading on Wednesday, materials shares fell 0.9%.
Top Headline
IHS Markit Ltd INFO 0.63% reported upbeat earnings for its fourth quarter.
IHS Markit reported quarterly earnings of $0.72 per share, beating analysts’ expectations of $0.67 per share. The company posted sales of $1.11 billion, versus estimates of $1.11 billion.
Equities Trading UP
Live Ventures Incorporated LIVE 93.45% shares shot up 79% to $22.49 after the company swung to a profit in the fourth quarter.
Shares of Motorsport Games Inc. NASDAQMSGM got a boost, shooting 58% to $31.50 after the company priced its IPO at $20 per share.
GameStop Corp. GME 67.13% shares were also up, gaining 69% to $33.62 following the recent addition of new board members, including from Chewy. Baird analyst Wednesday said new board configuration could suggest company is accelerating its digital transformation plan.
Equities Trading DOWN
Harbor Custom Development, Inc. HCDI 13.11% shares tumbled 14% to $3.0350 after the company priced its public offering of 8,000,000 shares of its common stock at $3.00 per share.
Shares of Esperion Therapeutics, Inc. ESPR 11.88% were down 11% to $26.82. Esperion said it sees Q4 US net product sales $8 million to $8.5 million.
Provention Bio, Inc. PRVB 14.13% was down, falling 12% to $17.16 as the company said it has commenced an underwritten public offering of 6 million shares of its common stock. All of the shares to be sold in the offering are to be sold by the company.
Commodities
In commodity news, oil traded down 0.6% to $52.92, while gold traded up 0.6% to $1,854.50.
Silver traded up 0.3% Wednesday to $25.52 while copper rose 0.3% to $3.6160.
Euro zone
European shares closed mostly higher today. The eurozone’s STOXX 600 rose 0.11%, the Spanish Ibex Index rose 0.18% and the German DAX 30 gained 0.11%. Meanwhile, the French CAC 40 rose 0.21%, London’s FTSE 100 dropped 0.13% and Italy’s FTSE MIB gained 0.43%. German wholesale prices fell 1.2% year-over-year in December.
Economics
Annual inflation rate rose to 1.4% in December from 1.2 percent in November.
US crude oil inventories fell by 3.247 million barrels in the week ended January 8, 2021, the Energy Information Administration reported.
The Federal Open Market Committee released its Beige Book report.
Federal Reserve Vice Chair Richard Clarida will speak at 3:00 p.m. ET.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.